(0.12%) 5 254.82 points
(0.08%) 39 790 points
(-0.09%) 16 385 points
(2.07%) $83.03
(2.10%) $1.754
(1.21%) $2 239.50
(0.80%) $24.95
(1.32%) $921.70
(0.40%) $0.927
(0.81%) $10.86
(0.16%) $0.793
(0.20%) $92.62
Live Chart Being Loaded With Signals
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe...
Stats | |
---|---|
Today's Volume | 201 907 |
Average Volume | 294 499 |
Market Cap | 10.83B |
EPS | $0 ( 2024-02-14 ) |
Last Dividend | $0.170 ( 2023-09-06 ) |
Next Dividend | $0 ( N/A ) |
P/E | 154.85 |
ATR14 | $0.0730 (0.07%) |
Volume Correlation
Pro Medicus Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pro Medicus Ltd Correlation - Currency/Commodity
Pro Medicus Ltd Financials
Annual | 2023 |
Revenue: | $124.90M |
Gross Profit: | $92.37M (73.95 %) |
EPS: | $0.580 |
Q2 | 2023 |
Revenue: | $74.11M |
Gross Profit: | $54.62M (73.70 %) |
EPS: | $0.350 |
Q4 | 2023 |
Revenue: | $68.01M |
Gross Profit: | $50.71M (74.55 %) |
EPS: | $0.320 |
Q3 | 2022 |
Revenue: | $34.01M |
Gross Profit: | $33.88M (99.62 %) |
EPS: | $0.160 |
Financial Reports:
No articles found.
Pro Medicus Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.120 (N/A) |
$0 (N/A) |
$0.130 (N/A) |
$0 (N/A) |
$0.170 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0100 | 2001-03-16 |
Last Dividend | $0.170 | 2023-09-06 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | $1.503 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.26 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.06 | |
Div. Directional Score | 9.36 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NHC.AX | Ex Dividend Knight | 2023-10-23 | Annually | 0 | 0.00% | |
WPR.AX | Ex Dividend Junior | 2023-06-29 | Quarterly | 0 | 0.00% | |
FGG.AX | Ex Dividend Junior | 2023-10-05 | Annually | 0 | 0.00% | |
PMC.AX | Ex Dividend Junior | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
ASG.AX | Ex Dividend Junior | 2023-10-31 | Annually | 0 | 0.00% | |
IEL.AX | Ex Dividend Knight | 2023-09-04 | Annually | 0 | 0.00% | |
SCG.AX | Ex Dividend Junior | 2023-08-17 | Annually | 0 | 0.00% | |
CCV.AX | Ex Dividend Knight | 2023-09-14 | Annually | 0 | 0.00% | |
MAH.AX | Ex Dividend Knight | 2023-09-19 | Sporadic | 0 | 0.00% | |
TCL.AX | Ex Dividend Knight | 2023-06-29 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.490 | 1.500 | 0.190 | 0.285 | [0 - 0.5] |
returnOnAssetsTTM | 0.326 | 1.200 | 10.00 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.468 | 1.500 | 5.91 | 8.87 | [0.1 - 1] |
payoutRatioTTM | 0.449 | -1.000 | 5.51 | -5.51 | [0 - 1] |
currentRatioTTM | 7.49 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.45 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.25 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00721 | -1.500 | 9.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.658 | 2.00 | 9.67 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00970 | -1.500 | 9.96 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.741 | 1.000 | 0.982 | 0.982 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.673 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 48.73 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.664 | 0.800 | 8.91 | 7.13 | [0.5 - 2] |
Total Score | 11.67 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 155.28 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.468 | 2.50 | 7.37 | 8.87 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.658 | 2.00 | 9.78 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.338 | 1.500 | 1.558 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.449 | 1.500 | 5.51 | -5.51 | [0 - 1] |
pegRatioTTM | 3.58 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.530 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 7.06 |
Pro Medicus Ltd
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators